LivaNova Analyst Price Targets

Wall Street analyst price targets and consensus rating for LivaNova (LIVN).

Price Target Range — 13 Quarters

Analyst Consensus — 10 Analysts

9Buy

1Hold

Consensus RatingOutperform# Analysts10Avg. Consensus PT$79Upside to Avg. PT+3.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$105
Sep 2, 2026	Piper Sandler	Adam Maeder	PT Raise	Overweight	$87→$90
Aug 5, 2026	Needham	Mike Matson	PT Raise	Buy	$81→$93
Jul 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$90→$95
Jul 1, 2026	Freedom Capital Markets	Keith Hinton	Initiate	Hold	$81
Jun 22, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$83→$92
May 7, 2026	Barclays	Matt Miksic	PT Raise	Equal-Weight	$73→$76
May 7, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$85→$90
May 7, 2026	Baird	David Rescott	PT Cut	Outperform	$78→$76
Feb 27, 2026	Barclays	Matt Miksic	PT Raise	Equal-Weight	$67→$73
Feb 25, 2026	Needham	Mike Matson	PT Raise	Buy	$64→$81
Jan 9, 2026	Barclays	Matt Miksic	PT Raise	Equal-Weight	$58→$67
Jan 7, 2026	Stifel	Rick Wise	PT Raise	Buy	$65→$70
Dec 19, 2025	Keybanc	Brett Fishbin	Initiate	Overweight	$81
Dec 17, 2025	Mizuho	Anthony Petrone	PT Raise	Outperform	$70→$72
Nov 13, 2025	Mizuho	Anthony Petrone	PT Raise	Outperform	$65→$70
Nov 13, 2025	Baird	David Rescott	PT Raise	Outperform	$63→$70
Nov 6, 2025	Baird	David Rescott	PT Raise	Outperform	$61→$63
Sep 3, 2025	Needham	Mike Matson	Maintained	Buy	$64
Aug 21, 2025	Barclays	Matt Miksic	PT Raise	Equal-Weight	$55→$58

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Initiates Coverage On LivaNova with Overweight Rating, Announces Price Target of $105

Barclays analyst Christopher Pasquale initiates coverage on LivaNova (NASDAQ:LIVN) with a Overweight rating and announces Price Target of $105.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on LivaNova, Raises Price Target to $90

Piper Sandler analyst Adam Maeder reiterates LivaNova (NASDAQ:LIVN) with a Overweight and raises the price target from $87 to $90.

Benzinga Newsdesk

PRO
Needham Maintains Buy on LivaNova, Raises Price Target to $93

Needham analyst Mike Matson maintains LivaNova (NASDAQ:LIVN) with a Buy and raises the price target from $81 to $93.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on LivaNova, Raises Price Target to $95

Mizuho analyst Anthony Petrone maintains LivaNova (NASDAQ:LIVN) with a Outperform and raises the price target from $90 to $95.

Benzinga Newsdesk

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on top names. See the latest analyst ratings and coverage on stocks like ABT, LIVN, AMPL, LION, and HONA.

Avi Kapoor

PRO
Freedom Capital Markets Initiates Coverage On LivaNova with Hold Rating, Announces Price Target of $81

Freedom Capital Markets analyst Keith Hinton initiates coverage on LivaNova (NASDAQ:LIVN) with a Hold rating and announces Price Target of $81.

Benzinga Newsdesk

LivaNova PLC

LivaNova Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Barclays Initiates Coverage On LivaNova with Overweight Rating, Announces Price Target of $105

PRO
Piper Sandler Reiterates Overweight on LivaNova, Raises Price Target to $90

PRO
Needham Maintains Buy on LivaNova, Raises Price Target to $93

PRO
Mizuho Maintains Outperform on LivaNova, Raises Price Target to $95

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
Freedom Capital Markets Initiates Coverage On LivaNova with Hold Rating, Announces Price Target of $81

People Also Watch

People Also Watch

LivaNova PLC

LivaNova Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBarclays Initiates Coverage On LivaNova with Overweight Rating, Announces Price Target of $105

PROPiper Sandler Reiterates Overweight on LivaNova, Raises Price Target to $90

PRONeedham Maintains Buy on LivaNova, Raises Price Target to $93

PROMizuho Maintains Outperform on LivaNova, Raises Price Target to $95

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROFreedom Capital Markets Initiates Coverage On LivaNova with Hold Rating, Announces Price Target of $81

People Also Watch

People Also Watch

PRO
Barclays Initiates Coverage On LivaNova with Overweight Rating, Announces Price Target of $105

PRO
Piper Sandler Reiterates Overweight on LivaNova, Raises Price Target to $90

PRO
Needham Maintains Buy on LivaNova, Raises Price Target to $93

PRO
Mizuho Maintains Outperform on LivaNova, Raises Price Target to $95

PRO
Freedom Capital Markets Initiates Coverage On LivaNova with Hold Rating, Announces Price Target of $81